These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20549523)

  • 1. Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.
    Maguire-Zeiss KA; Federoff HJ
    J Neural Transm (Vienna); 2010 Aug; 117(8):1019-25. PubMed ID: 20549523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
    Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
    Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.
    Al-Nusaif M; Lin Y; Li T; Cheng C; Le W
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neuroinflammation on the pathogenesis of Parkinson's disease.
    Chung YC; Ko HW; Bok E; Park ES; Huh SH; Nam JH; Jin BK
    BMB Rep; 2010 Apr; 43(4):225-32. PubMed ID: 20423606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease.
    Federoff HJ
    Neurotox Res; 2009 Oct; 16(3):261-70. PubMed ID: 19526279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.
    Kim YS; Joh TH
    Exp Mol Med; 2006 Aug; 38(4):333-47. PubMed ID: 16953112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?
    Tansey MG; Frank-Cannon TC; McCoy MK; Lee JK; Martinez TN; McAlpine FE; Ruhn KA; Tran TA
    Front Biosci; 2008 Jan; 13():709-17. PubMed ID: 17981581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.
    Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets.
    Yang L; Mao K; Yu H; Chen J
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):830-837. PubMed ID: 32529463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory response in Parkinson's disease (Review).
    Yan J; Fu Q; Cheng L; Zhai M; Wu W; Huang L; Du G
    Mol Med Rep; 2014 Nov; 10(5):2223-33. PubMed ID: 25215472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.
    Qian L; Flood PM; Hong JS
    J Neural Transm (Vienna); 2010 Aug; 117(8):971-9. PubMed ID: 20571837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
    J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.
    Kustrimovic N; Marino F; Cosentino M
    Curr Med Chem; 2019; 26(20):3719-3753. PubMed ID: 30306855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peli1 controls the survival of dopaminergic neurons through modulating microglia-mediated neuroinflammation.
    Dai D; Yuan J; Wang Y; Xu J; Mao C; Xiao Y
    Sci Rep; 2019 May; 9(1):8034. PubMed ID: 31142803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.